EPISODE · Feb 14, 2024 · 38 MIN
Disrupting Drug Discovery and Development With AI
from Data Science Leaders
There is no such thing as an AI drug, but AI and ML-models are driving the next wave of new treatments. In this episode, Brandon Allgood, Chief Data Officer at FogPharma and serial entrepreneur at the intersection of ML and Biopharma, shares his insights on how AI is disrupting the traditional process of drug discovery and development.Join us as we discuss: Why AI is so powerful for drug discoveryWhat data science needs to learn from engineeringHow drug discovery processes need to be rebuilt with AI models at their core
What this episode covers
There is no such thing as an AI drug, but AI and ML-models are driving the next wave of new treatments. In this episode, Brandon Allgood, Chief Data Officer at FogPharma and serial entrepreneur at the intersection of ML and Biopharma, shares his insights on how AI is disrupting the traditional process of drug discovery and development.Join us as we discuss: Why AI is so powerful for drug discoveryWhat data science needs to learn from engineeringHow drug discovery processes need to be rebuilt with AI models at their core
NOW PLAYING
Disrupting Drug Discovery and Development With AI
No transcript for this episode yet
Similar Episodes
No similar episodes found.